Development of cell-based adjuvant and tumor vaccine
碩士 === 高雄醫學大學 === 醫學遺傳學研究所碩士班 === 94 === we are developing a novel cell adjuvant for naïve targeted-protein immunization. Endogenous Balb/3T3 mouse fibroblast cell was engineered to express mouse membrane IL-2,GM-CSF and IL-18 as cell adjuvents for immunization. We have demonstrated that functional...
Main Authors: | Tzu-Ying Chiang, 江姿瑩 |
---|---|
Other Authors: | 林綉茹 |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/58356372508694009743 |
Similar Items
-
Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant
by: Tinkara Remic, et al.
Published: (2020-03-01) -
Cytokine adjuvants for infectious bursal disease vaccine
by: Yi-Ying Lin, et al.
Published: (2008) -
Vaxjo: A Web-Based Vaccine Adjuvant Database and Its Application for Analysis of Vaccine Adjuvants and Their Uses in Vaccine Development
by: Samantha Sayers, et al.
Published: (2012-01-01) -
The Anti-tumoral Feasibility of Using Imiquimod as an Adjuvant to Enhance the Efficiency of ICD-based Dendritic Cell Vaccine
by: Hsin-Yu Wang, et al.
Published: (2017) -
Development of Immunomodulatory Adjuvants in Avian Vaccines
by: Li-Hsiang Hung, et al.
Published: (2012)